Phase 1 Study of KHK2898 in Subjects With Advanced Solid Tumors

Summary

This is a two-part, Phase 1 open label, single-center, dose escalation study of KHK2898 as monotherapy in subjects with advanced solid tumors who no longer respond to standard therapy or for whom no standard therapy is available.

Timeline

Start

2012-01

Primary completion

2015-05

Completion

2015-05

Drugs

Indications